P Schuetz

Summary

Publications

  1. ncbi Clinical outcomes associated with procalcitonin algorithms to guide antibiotic therapy in respiratory tract infections
    Philipp Schuetz
    Medical University Department, Kantonsspital Aarau, Tellstrasse, CH 5001 Aarau, Switzerland
    JAMA 309:717-8. 2013
  2. ncbi Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections
    Philipp Schuetz
    Department of Emergency Medicine, Harvard School of Public Health, Boston, MA, USA
    Cochrane Database Syst Rev 9:CD007498. 2012
  3. ncbi Procalcitonin to guide initiation and duration of antibiotic treatment in acute respiratory infections: an individual patient data meta-analysis
    Philipp Schuetz
    Department of Emergency Medicine, Beth Israel Deaconess Medical Center, and Harvard School of Public Health, Boston, MA 02115, USA
    Clin Infect Dis 55:651-62. 2012
  4. ncbi Initial management of septic patients with hyperglycemia in the noncritical care inpatient setting
    Philipp Schuetz
    Department of Emergency Medicine, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA
    Am J Med 125:670-8. 2012
  5. ncbi Role of procalcitonin in managing adult patients with respiratory tract infections
    Philipp Schuetz
    Harvard School of Public Health, Department of Medicine, Massachusetts General Hospital, Boston, MA 02115, USA
    Chest 141:1063-73. 2012
  6. ncbi Value of arterial blood gas analysis in patients with acute dyspnea: an observational study
    Emanuel Burri
    Department of Internal Medicine, University Hospital Basel, Petersgraben 4, Basel, Switzerland
    Crit Care 15:R145. 2011
  7. ncbi Enhancement of CURB65 score with proadrenomedullin (CURB65-A) for outcome prediction in lower respiratory tract infections: derivation of a clinical algorithm
    Werner C Albrich
    Medical University Department of the University of Basel, Kantonsspital Aarau, Switzerland
    BMC Infect Dis 11:112. 2011
  8. ncbi Prognostic value of procalcitonin in community-acquired pneumonia
    P Schuetz
    Harvard School of Public Health, Boston, MA 02115, USA
    Eur Respir J 37:384-92. 2011
  9. ncbi Quality of care delivered by fee-for-service and DRG hospitals in Switzerland in patients with community-acquired pneumonia
    Philipp Schuetz
    Department of Emergency Medicine, Beth Israel Deaconess Medical Center, and Harvard School of Public Health, Boston, MA, USA
    Swiss Med Wkly 141:w13228. 2011
  10. ncbi Repeated measurements of endothelin-1 precursor peptides predict the outcome in community-acquired pneumonia
    Philipp Schuetz
    Harvard School of Public Health, 677 Huntington Avenue, Boston, MA 02115, USA
    Intensive Care Med 37:970-80. 2011

Collaborators

Detail Information

Publications13

  1. ncbi Clinical outcomes associated with procalcitonin algorithms to guide antibiotic therapy in respiratory tract infections
    Philipp Schuetz
    Medical University Department, Kantonsspital Aarau, Tellstrasse, CH 5001 Aarau, Switzerland
    JAMA 309:717-8. 2013
    ....
  2. ncbi Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections
    Philipp Schuetz
    Department of Emergency Medicine, Harvard School of Public Health, Boston, MA, USA
    Cochrane Database Syst Rev 9:CD007498. 2012
    ....
  3. ncbi Procalcitonin to guide initiation and duration of antibiotic treatment in acute respiratory infections: an individual patient data meta-analysis
    Philipp Schuetz
    Department of Emergency Medicine, Beth Israel Deaconess Medical Center, and Harvard School of Public Health, Boston, MA 02115, USA
    Clin Infect Dis 55:651-62. 2012
    ..We undertook an individual patient data meta-analysis to assess safety of this approach in different ARI diagnoses and different clinical settings...
  4. ncbi Initial management of septic patients with hyperglycemia in the noncritical care inpatient setting
    Philipp Schuetz
    Department of Emergency Medicine, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA
    Am J Med 125:670-8. 2012
    ..The impact of hyperglycemia and glycemic control in patients with infection before developing severe sepsis or shock remains undefined...
  5. ncbi Role of procalcitonin in managing adult patients with respiratory tract infections
    Philipp Schuetz
    Harvard School of Public Health, Department of Medicine, Massachusetts General Hospital, Boston, MA 02115, USA
    Chest 141:1063-73. 2012
    ....
  6. ncbi Value of arterial blood gas analysis in patients with acute dyspnea: an observational study
    Emanuel Burri
    Department of Internal Medicine, University Hospital Basel, Petersgraben 4, Basel, Switzerland
    Crit Care 15:R145. 2011
    ..The diagnostic and prognostic value of arterial blood gas analysis (ABGA) parameters in unselected patients presenting with acute dyspnea to the Emergency Department (ED) is largely unknown...
  7. ncbi Enhancement of CURB65 score with proadrenomedullin (CURB65-A) for outcome prediction in lower respiratory tract infections: derivation of a clinical algorithm
    Werner C Albrich
    Medical University Department of the University of Basel, Kantonsspital Aarau, Switzerland
    BMC Infect Dis 11:112. 2011
    ..We aimed to derive a practical algorithm combining the CURB65 score with ProADM-levels in patients with community-acquired pneumonia (CAP) and non-CAP-LRTI...
  8. ncbi Prognostic value of procalcitonin in community-acquired pneumonia
    P Schuetz
    Harvard School of Public Health, Boston, MA 02115, USA
    Eur Respir J 37:384-92. 2011
    ..However, PCT was helpful during follow-up and for prediction of adverse events and, thereby, improved the PSI and CURB65 scores...
  9. ncbi Quality of care delivered by fee-for-service and DRG hospitals in Switzerland in patients with community-acquired pneumonia
    Philipp Schuetz
    Department of Emergency Medicine, Beth Israel Deaconess Medical Center, and Harvard School of Public Health, Boston, MA, USA
    Swiss Med Wkly 141:w13228. 2011
    ....
  10. ncbi Repeated measurements of endothelin-1 precursor peptides predict the outcome in community-acquired pneumonia
    Philipp Schuetz
    Harvard School of Public Health, 677 Huntington Avenue, Boston, MA 02115, USA
    Intensive Care Med 37:970-80. 2011
    ..Our aim was to investigate precursor peptides of endothelin-1 (proET1) on admission and during follow-up on days 3, 5 and 7 in a prospective cohort of 925 patients with community-acquired pneumonia...
  11. ncbi Influence of diabetes on endothelial cell response during sepsis
    P Schuetz
    Department of Emergency Medicine, Beth Israel Deaconess Medical Center, 1 Deaconess Road, CC2 W, Boston, MA 02215, USA
    Diabetologia 54:996-1003. 2011
    ..The objective of this analysis was to investigate the influence of diabetes on biomarkers of endothelial cell activation in sepsis...
  12. ncbi Optimised patient transfer using an innovative multidisciplinary assessment in Kanton Aargau (OPTIMA I): an observational survey in lower respiratory tract infections
    W C Albrich
    Medical University Department of the University of Basel, Kantonsspital Aarau, Tellstrasse, CH
    Swiss Med Wkly 141:w13237. 2011
    ..We describe our current triage practice and assess the potential of a combination of CURB65 with proadrenomedullin (ProADM) levels for triage decisions...
  13. ncbi Influence of procalcitonin on decision to start antibiotic treatment in patients with a lower respiratory tract infection: insight from the observational multicentric ProREAL surveillance
    F Dusemund
    Medical University Department, Kantonsspital Aarau, Tellstrasse, CH 5001, Aarau, Switzerland
    Eur J Clin Microbiol Infect Dis 32:51-60. 2013
    ..Differential compliance with antibiotic stewardship efforts contributes to geographical differences in antibiotic prescribing habits and potentially influences antibiotic resistance rates...